- Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies
David B Zhen et al, 2019, Journal of Oncology Pharmacy Practice CrossRef - Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
Aurélien Lambert et al, 2017, Therapeutic Advances in Gastroenterology CrossRef - Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatin
Diana Varghese et al, 2022, Journal of Oncology Pharmacy Practice CrossRef - Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
Mariagrazia De Lisa et al, 2020, Oncology and Therapy CrossRef